MIRA biotech catalysts & pipeline

MIRA PHARMACEUTICALS INC · Data as of 2026-10-25

Upcoming catalysts

MIRA-55 — IND submission

Q1 2027

MIRA is advancing MIRA-55 toward a planned IND submission in the first quarter of 2027, subject to completion of the remaining required preclinical and regulatory activities.

Source filing

Ketamir-2 — Conference presentation

in October

MIRA also expects to participate in BioJapan in October as the Company continues licensing and strategic partnership discussions around Ketamir-2 and its broader pipeline.

Source filing

Explore the free biotech catalyst calendar